releases: http://www.brown.senate.gov/newsroom/press/release/brown-touts-funding-to-stop-spread-of-drug-resistant-bacteria-combat-antibiotic-resistance
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| http://www.brown.senate.gov/newsroom/press/release/brown-touts-funding-to-stop-spread-of-drug-resistant-bacteria-combat-antibiotic-resistance | Brown Touts Funding to Stop Spread of Drug-Resistant Bacteria, Combat Antibiotic Resistance | 2015-12-18 | 2015 | 2015-12 | Democrat | House | OH | Sherrod Brown | B000944 | www.brown.senate.gov | legacy | Brown Plans to Reintroduce Legislation to Strengthen Federal Response to Antibiotic Resistance Friday, December 18, 2015 WASHINGTON, D.C. U.S. Sen. Sherrod Brown (D-OH) today announced that significant funding to stop the spread of drug-resistant bacteria was included in the fiscal year (FY) 2016 appropriations bill, which passed today. In addition to robust funding for antibiotic research activities at the U.S. Food and Drug Administration (FDA) and the U.S. Centers for Disease Control and Prevention (CDC), this legislation directs the CDC to coordinate with the Biomedical Advanced Research and Development Authority (BARDA), the National Institute for Allergy and Infectious Diseases (NIAID), and other government agencies to support collaboration among medical centers and schools, public health departments, and other academic institutions that focus on strategies to address antibiotic resistance. Antibiotic resistance and the emergence of super-bugs are a major threat to public health, said Brown. To stop the spread of these potentially deadly bacteria, we must support the FDA and CDC in their efforts to work with medical institutions and departments of health to tackle this issue. The robust funding included in the omnibus spending bill will help enhance research activities and help us preserve the effective antibiotics we currently have. Ill continue to engage stakeholders from public and private entities including Ohios many hospitals and research institutions to generate new ideas to address this issue. I am pleased that Congress has provided significant new funding to combat the growing problem of antibiotic resistant bacteria, and I commend Senator Brown for his ongoing efforts to address this public health challenge, said Dr. Sheldon M. Retchin, executive vice president of Health Sciences of The Ohio State University and chief executive officer of OSU Wexner Medical Center. Through Ohio State Universitys Wexner Medical Center and our Universitys health science colleges, we use multidisciplinary teams to study the development and transmission of antimicrobial resistant pathogens. A greater federal investment in this area will accelerate research nationally and, ultimately, solutions. These funds will support the essential work being conducted in research institutions like CaseWestern Reserve University School of Medicine, where there is an ongoing effort to evaluate infection control and prevention approaches, initiate clinical trials of new antibiotics,and study the mechanisms through which these disease-causing microbes develop resistance to antibiotics, said Dr. Robert Salata, Professor and Interim Chair of the Department of Medicine, at the medical school, and Physician-in-Chief at University Hospitals Case Medical Center. Support provided by this bill willadvance research efforts to develop new drugs and discover novel approachesto address this national and international problem. The bill includes: $8.7 million for the FDA and $10 million for the Agency for Healthcare Research and Quality (AHRQ) to work on the Combating Antibiotic Resistant Bacteria Initiative; $160 million for a new CDC initiative to combat threat of antibiotic bacteria; $100 million for antimicrobial resistance research at the National Institute of Allergy and Infectious Disease; and Language that instructs the CDC to support states in the use of evidence-based approaches to stop the spread of drug-resistant bacteria and preserve existing antibiotics. Brown has been working to combat antibiotic-resistant infections, which affect more than two million Americans each year. In 2014, Brown introduced the Strategies to Address Antimicrobial Resistance (STAAR) Act, which would strengthen the federal response to antibiotic resistance by promoting prevention and control; tracking drug-resistant bacteria; and supporting enhanced research efforts; as well as improving the development, use, and stewardship of antibiotics. Brown will reintroduce similar legislation next year. ### Press Contact Lauren Kulik/Rachel Petri(202) 224-3978 | 1 | 2026-03-30T12:14:52Z | 2026-03-30T12:14:52Z |